Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.

Zhang YJ, Xu WD, Duan ZH, Liu SS, Pan HF, Ye DQ.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S46-50. Epub 2012 Sep 25. Review.

PMID:
23010350
2.

Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.

Zhang C, Hou WH, Ding XX, Wang X, Zhao H, Han XW, Wang WJ.

Asian Pac J Cancer Prev. 2016;17(8):3785-91.

3.

The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population.

Du L, Yang J, Huang J, Ma Y, Wang H, Xiong T, Xiang Z, Zhang Y, Huang J.

BMC Med Genet. 2013 Apr 19;14:46. doi: 10.1186/1471-2350-14-46.

4.

Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.

Zhang Y, Zhang J, Deng Y, Tian C, Li X, Huang J, Fan H.

Cancer. 2011 Sep 15;117(18):4312-24. doi: 10.1002/cncr.25979. Epub 2011 Mar 8.

5.

CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.

Lee YH, Song GG.

Mol Biol Rep. 2012 Sep;39(9):9041-5. doi: 10.1007/s11033-012-1775-9. Epub 2012 Jun 22.

PMID:
22722994
6.

Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.

Zhu CL, Huang Q, Liu CH, Xie F.

Mol Biol Rep. 2012 Sep;39(9):8701-8. doi: 10.1007/s11033-012-1727-4. Epub 2012 Jun 19.

PMID:
22711308
7.

Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.

Liang J, Zhang S, Luo Q, Li W, Tian X, Zhang F, Zhao T, Chen X, Zhang X.

Gene. 2015 Sep 1;568(2):196-202. doi: 10.1016/j.gene.2015.05.051. Epub 2015 May 24.

PMID:
26013045
8.

Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.

Xia W, Shi R, Zheng WL, Ma WL.

Technol Cancer Res Treat. 2013 Dec;12(6):565-74. doi: 10.7785/tcrt.2012.500350. Epub 2013 Jun 6.

PMID:
23745791
9.

Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.

Gunesacar R, Erken E, Dinkci S.

Cell Biochem Biophys. 2013 Mar;65(2):181-6. doi: 10.1007/s12013-012-9416-4.

PMID:
22923220
10.

Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis.

Dai Z, Feng C, Zhang W, Liu J, Cao X, Zhang H, Liu Y, Wang M, Liu X, Dai Z.

Ann Hematol. 2016 Oct;95(10):1685-94. doi: 10.1007/s00277-016-2753-4. Epub 2016 Aug 8.

PMID:
27498821
11.

CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.

Sallakci N, Bacanli A, Coskun M, Yavuzer U, Alpsoy E, Yegin O.

Clin Exp Dermatol. 2005 Sep;30(5):546-50.

PMID:
16045690
12.

Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.

Geng R, Song F, Yang X, Sun P, Hu J, Zhu C, Zhu B, Fan W.

Tumour Biol. 2014 Apr;35(4):3627-39. doi: 10.1007/s13277-013-1480-x. Epub 2013 Dec 5.

PMID:
24307627
13.

CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Zhao JJ, Wang D, Yao H, Sun DW, Li HY.

World J Gastroenterol. 2015 Sep 14;21(34):10025-40. doi: 10.3748/wjg.v21.i34.10025. Review.

14.

CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.

Zhai JX, Zou LW, Zhang ZX, Fan WJ, Wang HY, Liu T, Ren Z, Dai RX, Ye D.

Mol Biol Rep. 2013 Sep;40(9):5213-23. doi: 10.1007/s11033-012-2125-7. Epub 2013 Aug 7.

PMID:
23922195
15.

[Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].

Yi B, Pei Y, Wang C, Jiang Y.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Aug;32(8):1099-104. Chinese.

PMID:
27412943
16.

Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.

Wang NG, Wang DC, Tan BY, Wang F, Yuan ZN.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7421-5. eCollection 2015.

17.

Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.

Gao X, Zhang S, Qiao X, Yao Y, Wang L, Dong D, Ma X, Wang T.

Cancer Biomark. 2014;14(4):287-94. doi: 10.3233/CBM-140403.

PMID:
24934372
18.

No association of CTLA-4 polymorphisms with susceptibility to Behçet disease.

Du L, Yang P, Hou S, Zhou H, Kijlstra A.

Br J Ophthalmol. 2009 Oct;93(10):1378-81. doi: 10.1136/bjo.2008.156919. Epub 2009 Jun 30. Review.

PMID:
19570770
19.

The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer.

Liu P, Xu L, Sun Y, Wang Z.

Tumour Biol. 2014 Apr;35(4):2893-903. doi: 10.1007/s13277-013-1457-9. Epub 2013 Dec 10. Review.

PMID:
24317815
20.

Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease.

Gunesacar R, Erken E, Bozkurt B, Ozer HT, Dinkci S, Erken EG, Ozbalkan Z.

Int J Immunogenet. 2007 Feb;34(1):45-9.

PMID:
17284227

Supplemental Content

Support Center